exclusive, exclusive, or partially exclusive: Treatment of and/or prophylaxis against brain and spinal cord injury,

[Federal Register: November 6, 2001 (Volume 66, Number 215)]

[Notices]

[Page 56088]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr06no01-38]

DEPARTMENT OF DEFENSE

Department of the Army

Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Treatment of and/or Prophylaxis Against Brain and Spinal Cord Injury

AGENCY: Army Medical Research and Materiel Command, DOD.

ACTION: Notice.

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the availability for licensing of U.S. Patent Application No. 09/556,954 entitled ``Treatment of and/or Prophylaxis Against Brain and Spinal Cord Injury'' and filedApril 21, 2000. The United States Government, as represented by the Secretary of the Army, has rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619-6664. Both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The administration of -lipoic acid (-LA) and dihydrolipoic acid (DHL) both as a preventive measure before exposure to conditions which may cause damage, such as rapid changes in atmospheric pressure, and as a means of preventing or ameliorating damage arising from such injury provides benefits not currently available. The active agents may be administered systematically or to the injured tissue. For example, when there is spinal cord injury, the active agents may be administered intrathecally.

Luz D. Ortiz, Army Federal Register Liaison Officer.

[FR Doc. 01-27866Filed11-5-01; 8:45 am]

BILLING CODE 3710-08-M